Deversify Health AB Logo

Deversify Health AB

Developed mobile breathalyzers and apps for metabolic health for consumers, businesses & healthcare.

DEV | ST

Overview

Corporate Details

ISIN(s):
SE0015660345 (+3 more)
LEI:
549300498ZGZ1NBYC361
Country:
Sweden
Address:
Skeppsbron 34,, 111 30 Stockholm
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Deversify Health AB was a Swedish health technology company specializing in research, development, and commercialization of solutions for personalized health. The company's primary focus was on mobile electronic breathalyzers, such as its flagship Acetrack device, and accompanying software applications designed to monitor biomarkers related to metabolic health. Its target markets included consumers, businesses, and healthcare providers. In addition to its hardware platform for breath analysis, Deversify offered educational services and programs centered on personal nutrition and wellness through its Elitista platform, acquired in 2021. Following a reverse acquisition by Euroafrica Digital Ventures in early 2024, the company was declared bankrupt and delisted from the Nasdaq First North Growth Market in November 2024.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Deversify Health AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Deversify Health AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Deversify Health AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BECTON DICKINSON & CO Logo
Develops medical supplies, devices & diagnostics for healthcare and life science researchers.
United States of America
BDX
BELLUSCURA PLC Logo
Develops portable oxygen concentrators for patients needing supplemental oxygen.
United Kingdom
BELL
BENO TNR, Inc. Logo
A diversified firm in biotech, wearable robotics, and eco-friendly building materials.
South Korea
206400
Beta Bionics, Inc. Logo
Develops an automated insulin delivery system to simplify management of type 1 diabetes.
United States of America
BBNX
BibbInstruments AB Logo
Develops electric endoscopic biopsy tools for accurate cancer diagnosis in GI, lung, and urology.
Sweden
BIBB
BIOBIJOU Co., Ltd. Logo
Develops and manufactures injectable aesthetic solutions like HA fillers for global markets.
South Korea
489460
Biocartis Group NV Logo
Develops an automated PCR platform for fast molecular diagnostics in oncology & infectious diseases.
Belgium
BCART
Biocorp Logo
Develops and manufactures connected drug delivery systems and medical devices for pharma.
France
ALCOR
BIODESIX INC Logo
Develops blood-based diagnostic tests for lung disease to guide personalized treatment decisions.
United States of America
BDSX
BIODYNE CO., LTD. Logo
Develops automated liquid-based cytology systems and reagents for cancer diagnostics.
South Korea
314930

Talk to a Data Expert

Have a question? We'll get back to you promptly.